Security
VBIO · Valion Bio, Inc.
VBIONASDAQCommon stockCurrentCIK 1787740Updated Sep 26, 2026
Name history
Tivic Health Systems, Inc. · through Apr 23, 2026
VBIO price & chart
Loading TradingView…
NASDAQ:VBIO on TradingView ↗About the company
We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act. An emerging growth company may take advantage of specified reduced reporting requirements that are otherwise generally applicable to public companies. As a result:
In the news
No coverage from other publishers is available.
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
SCHEDULE 13G/A filing
SCHEDULE 13D/A filing
SCHEDULE 13D/A filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 1.01, 3.02, 5.02, 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 31,607,000Source | 2,807,000Source | 5,157,000Source | 5,856,000Source |
| Property, Plant and Equipment, NetUSD | 12,641,000Source | 119,000Source | 122,000Source | 12,000Source |
| GoodwillUSD | 3,457,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,243,000Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,645,000Source | 2,002,000Source | 3,395,000Source | 3,517,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 69,000Source | 174,000Source | 88,000Source |
| Inventory, NetUSD | 0Source | 319,000Source | 756,000Source | 863,000Source |
| Assets, CurrentUSD | 13,006,000Source | 2,639,000Source | 4,652,000Source | 5,287,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 346,000Source | 249,000Source | 327,000Source | 235,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | — | 349,000Source | 523,000Source |
| Other Assets, NoncurrentUSD | 124,000Source | — | 34,000Source | 34,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 7,440,000Source | 272,000Source | 1,577,000Source | 2,226,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | — | — | — |
| Common Stock, Value, IssuedUSD | 2,000Source | 1,000Source | 0Source | 1,000Source |
| Additional Paid in CapitalUSD | 69,392,000Source | 46,075,000Source | 41,466,000Source | 33,271,000Source |
| Retained Earnings (Accumulated Deficit)USD | -52,597,000Source | -43,541,000Source | -37,886,000Source | -29,642,000Source |
| Stockholders' Equity Attributable to ParentUSD | 16,797,000Source | 2,535,000Source | 3,580,000Source | 3,630,000Source |
| Liabilities and EquityUSD | 31,607,000Source | 2,807,000Source | 5,157,000Source | 5,856,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 646,000Source | 272,000Source | 1,401,000Source | 1,859,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | 193,000Source | 163,000Source |
| Accounts Payable, CurrentUSD | 264,000Source | 125,000Source | 713,000Source | 1,323,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | 176,000Source | 367,000Source |
| Other Liabilities, NoncurrentUSD | 48,000Source | — | — | — |
| Additional Financial Items | ||||
| Deferred Revenue, CurrentUSD | — | — | — | 0Source |
| Deferred Tax Liabilities, NetUSD | — | 0Source | 97,000Source | 143,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | -5,655,000Source | -8,244,000Source | -10,096,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | 3,000Source | 8,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 564,000Source | 229,000Source | 271,000Source | 398,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | -105,000Source | 67,000Source | -4,000Source |
| Increase (Decrease) in InventoriesUSD | -16,253,000Source | -83,000Source | -75,000Source | 434,000Source |
| Increase (Decrease) in Accounts PayableUSD | 139,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -6,999,000Source | -5,725,000Source | -8,511,000Source | -8,919,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -705,000Source | — | -118,000Source | -11,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 38,000Source | — | 118,000Source | 11,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 18,347,000Source | 4,332,000Source | 8,507,000Source | -528,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 10,643,000Source | -1,393,000Source | -122,000Source | -9,458,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 12,645,000Source | 2,002,000Source | 3,395,000Source | 3,517,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 0Source | — | — | — |
| Additional Financial Items | ||||
| AmortizationUSD | 97,000Source | — | — | — |
| Share-based Payment Arrangement, ExpenseUSD | 564,000Source | 229,000Source | 271,000Source | 398,000Source |
| DepreciationUSD | 5,000Source | 3,000Source | 8,000Source | 10,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 28,000Source | — | — | — |
| Gain (Loss) on Termination of LeaseUSD | — | 60,000Source | — | — |
| General and Administrative ExpenseUSD | — | 3,163,000Source | 4,752,000Source | 5,875,000Source |
| GoodwillUSD | 3,457,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -7,993,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -885,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| InterestExpenseNonoperatingUSD | 146,000Source | — | — | — |
| Inventory Write-downUSD | — | 354,000Source | 32,000Source | — |
| Investment Income, InterestUSD | 23,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -8,878,000Source | -5,655,000Source | -8,244,000Source | -10,096,000Source |
| Nonoperating Income (Expense)USD | -95,000Source | 6,000Source | 1,000Source | 2,000Source |
| Operating ExpensesUSD | 7,898,000Source | 5,663,000Source | 8,532,000Source | 10,397,000Source |
| Proceeds from Issuance of Common StockUSD | 2,337,000Source | 4,381,000Source | 8,507,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 56,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | — | 780,000Source | 1,176,000Source | 1,840,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 4,767,000Source | — | — | — |
| Operating Income (Loss)USD | -7,898,000Source | -5,661,000Source | -8,245,000Source | -10,098,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -8,244,000Source | — |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -8,878,000Source | -5,655,000Source | -8,244,000Source | -10,096,000Source |
| Earnings Per Share, BasicUSD per share | -7.84Source | -19.68Source | -10.4Source | -1.04Source |
| Earnings Per Share, DilutedUSD per share | — | -19.68Source | -10.4Source | -1.04Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,155,531Source | 287,370Source | 793,043Source | 9,672,957Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | 287,370Source | 793,043Source | 9,672,957Source |
| Interest Expense (non-operating)USD | 146,000Source | — | — | — |
| Additional Financial Items | ||||
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 28,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | 3,163,000Source | 4,752,000Source | 5,875,000Source |
| Gross ProfitUSD | — | 2,000Source | 287,000Source | 299,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 8,900,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -7,993,000Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -885,000Source | — | — | — |
| Interest Income (Expense), NetUSD | — | 6,000Source | 1,000Source | 2,000Source |
| Investment Income, InterestUSD | 23,000Source | — | — | — |
| Marketing and Advertising ExpenseUSD | — | 500,000Source | 822,000Source | 1,300,000Source |
| Nonoperating Income (Expense)USD | -95,000Source | 6,000Source | 1,000Source | 2,000Source |
| Operating ExpensesUSD | 7,898,000Source | 5,663,000Source | 8,532,000Source | 10,397,000Source |
| Research and Development ExpenseUSD | 3,131,000Source | 1,313,000Source | 1,655,000Source | 1,730,000Source |
| Selling and Marketing ExpenseUSD | — | 1,187,000Source | 2,125,000Source | 2,792,000Source |
Offerings
Registration 333-297529
Registration 333-295029
Filing attachments
valion_ex107.htm · S-1 · 2026-07-17
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 Valion Bio, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Amount Registered Proposed Maximum Offering Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee …
Read attachment ↗tivic_ex107.htm · S-1 · 2026-04-13
Ex-Filing Fees CALCULATION OF FILING FEE TABLES S-1 Tivic Health Systems, Inc. Table 1: Newly Registered and Carry Forward Securities Line Item Type Security Type Security Class Title Notes Fee Calculation Amount Registered Proposed Maximum Offering Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee …
Read attachment ↗